Life Sciences

Sling Therapeutics Challenges Tepezza in Thyroid Eye Di...

Sling Therapeutics has achieved a milestone in the development of its oral treat...

Umoja Biopharma Secures $100 Million Series C Funding f...

Umoja Biopharma has successfully closed a $100 million Series C funding round, m...

Regenxbio And Nippon Sinyaku Pen $810M Gene Therapy Agr...

Regenxbio has struck a strategic partnership valued at $810 million with Japan’s...

Gilead Sciences Broadens Scope with $1.7 Billion Partne...

Gilead Sciences is further extending its reach beyond its roots in infectious di...

Blueprint Terminates Clinical-Stage CDK2 Inhibitor Prog...

Blueprint Medicines has announced the termination of its clinical-stage CDK2 inh...

J&J’s Lung Cancer Combo Outperforms Tagrisso in Surviva...

Johnson & Johnson has achieved a breakthrough in the treatment of non-small cell...

Merck’s HPV Vaccine Gets Green Light From China Regulator

According to a statement released by Merck, its human papillomavirus vaccination...

Tune Therapeutics Raises Whopping $175M to Bring Epigen...

Investors are clearly in no doubt over the functionality of Tune Therapeutics’ e...

Portage packages Tarus’ adenosine receptor antagonists ...

Over two years after taking over Tarus Therapeutics, Portage Biotech is reintrod...

Oculis’ Phase 2 Study Explores OCS-05 for Optic Nerve I...

A phase 2 clinical trial has assessed the effectiveness and safety of OCS-05, a ...

FDA Lays Out Guidelines Regarding Pulse Oximeter Accura...

To assist in ensuring that pulse oximeters function appropriately across all ski...

FDA Restricts Imports from Viatris’ India Facility Amid...

The U.S. Food and Drug Administration (FDA) has imposed restrictions on the impo...

Sanofi and SK bioscience advance their 21-Valent vaccin...

Sanofi has announced a new step forward in its collaboration with SK bioscience,...

SiteOne Therapeutics Secures $100 Million to Advance No...

Fifteen years ago, as concerns about the growing opioid crisis began to emerge, ...

FDA finally approves Novo Nordisk’s once-daily hemophil...

Novo Nordisk got a once-daily hemophilia injection cleared days before 2025. Nov...

Roche’s Acquisition of Spark Falls Short as Another The...

Roche’s 2019 acquisition of Philadelphia-based gene therapy specialist Spark The...